4 unknown, 3 completed, 1 recruiting, 1 terminated. 9 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Unknown 4, Completed 3, Recruiting 1, Terminated 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Helicobacter Infections: new trials by email Literature Review of Helicobacter Infections trials Research Report on Helicobacter Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Keverprazan-Minocycline Dual Therapy of Different Durations Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication. Minocycline, Keverprazan, Amoxicillin - Helicobacter Infection | Phase 3 | Recruiting | Nanjing First Hospital, Nanjing Medical University | 612 | 2026-07-15 | 2026-11-05 |
| Effectiveness of Rifabutin for Treatment of Helicobacter Pylori Rifabutin, Amoxicillin, Esomeprazole - Helicobacter Infections, Resistance Bacterial | Phase 3 | Unknown | Rabin Medical Center | 300 | 2021-05-01 | 2021-03-10 |
| A Unique Regimen for Treatment of Helicobacter Pylori Infection Quadruple therapy, Classic treatment - Helicobacter Infections | Phase 3 | Unknown | Sherief Abd-Elsalam | 600 | 2018-04-01 | 2018-04-10 |
| Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion Pylopass, Placebo - HELICOBACTER INFECTION | Phase 2 / Phase 3 | Completed | Atlantia Food Clinical Trials | 24 | 2014-01-01 | 2015-01-15 |
| Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy Omeprazole, amoxicillin, clarithromycin, Pylera (Bismuth subcitrate potassium, metronidazole, tetracycline) given in combination with omeprazole - Helicobacter Infections | Phase 3 | Completed | Forest Laboratories | 440 | 2008-06-01 | 2017-03-16 |
| Treating H. Pylori in Parkinson's Patients With Motor Fluctuations clartihromycin, amoxicillin, and omeprazole, placebo - Parkinson's Disease, Helicobacter Infections | Phase 3 | Terminated | University of California, Los Angeles | 64 | 2008-01-01 | 2017-12-02 |
| Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children Quadruple sequential Helicobacter pylori eradication + iron sulfate, Quadruple sequential Helicobacter pylori eradication therapy, Ferrous sulfate - Iron Deficiency | Phase 3 | Completed | The University of Texas Health Science Center, Houston | 125 | 2007-03-01 | 2009-06-30 |
| Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection rabeprazole, amoxicillin, clarithromycin, metronidazole - Helicobacter Infections, Gastritis | Phase 2 / Phase 3 | Unknown | Hamamatsu University | 2003-08-01 | 2006-03-21 | |
| Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori Lansoprazole, clarithromycin, amoxicillin - Helicobacter Infections, Gastritis | Phase 3 | Unknown | Hamamatsu University | 296 | 2003-04-01 | 2006-09-11 |
Duodenal Ulcer (2) · Gastritis (2) · Stomach Ulcer (2) · Iron Deficiencies (1) · Parkinson Disease (1)
Bacterial Infections (9) · Bacterial Infections and Mycoses (9) · Gram-Negative Bacterial Infections (9) · Infections (9) · Digestive System Diseases (2) · Duodenal Diseases (2) · Gastroenteritis (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Peptic Ulcer (2) · Stomach Diseases (2) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Iron Metabolism Disorders (1)
Amoxicillin (6) · Clarithromycin (5) · Metronidazole (2) · Omeprazole (2) · Esomeprazole (1) · Iron-Dextran Complex (1) · Lansoprazole (1) · Minocycline (1) · Rabeprazole (1) · Rifabutin (1) · Tetracycline (1) · Tinidazole (1) · ferrous sulfate (1)
Hamamatsu University (2) · Atlantia Food Clinical Trials (1) · Forest Laboratories (1) · Nanjing First Hospital, Nanjing Medical University (1) · Rabin Medical Center (1) · Sherief Abd-Elsalam (1) · The University of Texas Health Science Center, Houston (1) · University of California, Los Angeles (1)
Japan (2) · United States (2) · China (1) · Egypt (1) · Ireland (1) · United Kingdom (1)
Asem Elfert, Prof (1) · Ayman Yousry, Prof (1) · Doron Boltin, MBBS (1) · Hussein A Elamin, Prof (1) · Jeff M Bronstein, MD, PhD (1) · Martin JM Buckley, MRCPI, FRCPI (1) · Mohamed Adel Elbasiony, MD (1) · Mohamed Alboraie, MD (1) · Naohito Shirai, MD., PhD (1) · Sherief Abd-Elsalam, MD (1) · Takahisa Furuta, MD, PhD (1) · Victor M Cardenas, MD, MPH, PhD (1) · Walied El-Hossary, MD (1)
PMID 11197288, PMID 16441468, PMID 21336156, PMID 21336159, PMID 21345487, PMID 32153909, PMID 32365359, PMID 33037845